324 related articles for article (PubMed ID: 26273102)
1. 15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1-5.
Benn DE; Robinson BG; Clifton-Bligh RJ
Endocr Relat Cancer; 2015 Aug; 22(4):T91-103. PubMed ID: 26273102
[TBL] [Abstract][Full Text] [Related]
2. The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications.
Stratakis CA; Carney JA
J Intern Med; 2009 Jul; 266(1):43-52. PubMed ID: 19522824
[TBL] [Abstract][Full Text] [Related]
3. Familial paraganglioma syndromes.
Chetty R
J Clin Pathol; 2010 Jun; 63(6):488-91. PubMed ID: 20498024
[TBL] [Abstract][Full Text] [Related]
4. SDHAF2 (PGL2-SDH5) and hereditary head and neck paraganglioma.
Kunst HP; Rutten MH; de Mönnink JP; Hoefsloot LH; Timmers HJ; Marres HA; Jansen JC; Kremer H; Bayley JP; Cremers CW
Clin Cancer Res; 2011 Jan; 17(2):247-54. PubMed ID: 21224366
[TBL] [Abstract][Full Text] [Related]
5. Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia.
Gill AJ
Pathology; 2012 Jun; 44(4):285-92. PubMed ID: 22544211
[TBL] [Abstract][Full Text] [Related]
6. A review of the tumour spectrum of germline succinate dehydrogenase gene mutations: Beyond phaeochromocytoma and paraganglioma.
MacFarlane J; Seong KC; Bisambar C; Madhu B; Allinson K; Marker A; Warren A; Park SM; Giger O; Challis BG; Maher ER; Casey RT
Clin Endocrinol (Oxf); 2020 Nov; 93(5):528-538. PubMed ID: 32686200
[TBL] [Abstract][Full Text] [Related]
7. Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127).
Gupta S; Zhang J; Milosevic D; Mills JR; Grebe SK; Smith SC; Erickson LA
Endocr Pathol; 2017 Sep; 28(3):253-268. PubMed ID: 28646318
[TBL] [Abstract][Full Text] [Related]
8. Succinate dehydrogenase (SDH)-deficient neoplasia.
Gill AJ
Histopathology; 2018 Jan; 72(1):106-116. PubMed ID: 29239034
[TBL] [Abstract][Full Text] [Related]
9. [Paragangliomas and paraganglioma syndromes].
Boedeker CC
Laryngorhinootologie; 2011 Mar; 90 Suppl 1():S56-82. PubMed ID: 21523634
[TBL] [Abstract][Full Text] [Related]
10. Testing new susceptibility genes in the cohort of apparently sporadic phaeochromocytoma/paraganglioma patients with clinical characteristics of hereditary syndromes.
Pęczkowska M; Kowalska A; Sygut J; Waligórski D; Malinoc A; Janaszek-Sitkowska H; Prejbisz A; Januszewicz A; Neumann HP
Clin Endocrinol (Oxf); 2013 Dec; 79(6):817-23. PubMed ID: 23551045
[TBL] [Abstract][Full Text] [Related]
11. Potential Pitfalls of SDH Immunohistochemical Detection in Paragangliomas and Phaeochromocytomas Harbouring Germline
Santi R; Rapizzi E; Canu L; Ercolino T; Baroni G; Fucci R; Costa G; Mannelli M; Nesi G
Anticancer Res; 2017 Feb; 37(2):805-812. PubMed ID: 28179334
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and Management of Hereditary Phaeochromocytoma and Paraganglioma.
Lalloo F
Recent Results Cancer Res; 2016; 205():105-24. PubMed ID: 27075351
[TBL] [Abstract][Full Text] [Related]
13. [Hereditary pheochromocytoma and paraganglioma].
Musil Z; Vícha A; Zelinka T; Turková H; Labudová T; Kohoutová M; Pacák K
Klin Onkol; 2012; 25 Suppl():S21-6. PubMed ID: 22920202
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours.
Tsang VH; Dwight T; Benn DE; Meyer-Rochow GY; Gill AJ; Sywak M; Sidhu S; Veivers D; Sue CM; Robinson BG; Clifton-Bligh RJ; Parker NR
Endocr Relat Cancer; 2014 Jun; 21(3):415-26. PubMed ID: 24623741
[TBL] [Abstract][Full Text] [Related]
15. Functional consequences of succinate dehydrogenase mutations.
Opocher G; Schiavi F
Endocr Pract; 2011; 17 Suppl 3():64-71. PubMed ID: 21742608
[TBL] [Abstract][Full Text] [Related]
16. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
Astuti D; Hart-Holden N; Latif F; Lalloo F; Black GC; Lim C; Moran A; Grossman AB; Hodgson SV; Freemont A; Ramsden R; Eng C; Evans DG; Maher ER
Clin Endocrinol (Oxf); 2003 Dec; 59(6):728-33. PubMed ID: 14974914
[TBL] [Abstract][Full Text] [Related]
17. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
Neumann HP; Pawlu C; Peczkowska M; Bausch B; McWhinney SR; Muresan M; Buchta M; Franke G; Klisch J; Bley TA; Hoegerle S; Boedeker CC; Opocher G; Schipper J; Januszewicz A; Eng C;
JAMA; 2004 Aug; 292(8):943-51. PubMed ID: 15328326
[TBL] [Abstract][Full Text] [Related]
18. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
[TBL] [Abstract][Full Text] [Related]
19. Paragangliomas: update on differential diagnostic considerations, composite tumors, and recent genetic developments.
Papathomas TG; de Krijger RR; Tischler AS
Semin Diagn Pathol; 2013 Aug; 30(3):207-23. PubMed ID: 24144290
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]